No Flush Niacin 500 mg
80/100
This product is generally safe
- Niacin: 500mg is 14.3× the Tolerable Upper Intake Level (35mg)
- 50% of ingredients have research evidence
C
Label Compliance Grade
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Safety Alerts
⚠️ Niacin: 500mg is 14.3× the Tolerable Upper Intake Level (35mg)
Label Data
1 Tablet(s)
Serving Size
60
Servings
Single Vitamin and Mineral
Product Type
50%
Evidence Coverage
Supplement Facts — Evidence Check
500 mg
(3125% DV)
⚠️ Exceeds Tolerable Upper Intake Level by 14.3× (UL: 35 mg)
📚 193 studies (Tier A: 5, B: 63)
Calcium
150 mg
(12% DV)
Other Ingredients
Dicalcium Phosphate
Microcrystalline Cellulose
Stearic Acid
Silica
Croscarmellose Sodium
Magnesium Stearate
Hypromellose
Glycerin
Carnauba Wax
Talc
Label Claims — Verification
❓
All Other
❓
Structure/Function
All Other (97% of products)
Structure/Function (86% of products)
Nutrient (36% of products)
Target Groups
Vegan
Vegetarian
Adult (18 - 50 Years)
Gluten Free
Dairy Free
Sugar Free
Product Information
📋 Directions for Use
Directions: Take 1 tablet daily as a dietary supplement or as directed by a healthcare professional.
⚠️ Warnings & Precautions
Keep out of reach of children.
Do not purchase if seal is broken.
🧪 Formulation Notes
Made in the U.S.A. from globally sourced ingredients.
Inositol Hexanicotinate
Promotes heart health Boost healthy circulation
No sugar, wheat, soy, milk, artificial colors, flavors or preservatives Non GMO Gluten free
Vegan
Additional Information
Store in a cool, dry place.
H
Product Details
UPC / SKU
0 35046 00333 3
DSLD Entry Date
2024-07-25
Product Type
Single Vitamin and Mineral
Form
Tablet or Pill
DSLD ID
314024
Data Updated
2026-04-11
Research Evidence
241
Research Sources
55
Avg Quality Score
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A
Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
A
Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
A
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
A
Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
B
Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Compare Similar Products
Rezistaf
LifeLink
100
Coenzymated B-3 25 mg
Source Naturals
100
Vitamin B Complex
Simply Supplements
100
Test X180 Boost
Force Factor
100
8-Hour Alert
MHP Maximum Human Performance
100